Market revenue in 2023 | USD 78.4 million |
Market revenue in 2030 | USD 126.0 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Synthetic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 70.54% in 2023. Horizon Databook has segmented the Kuwait active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical sector of Kuwait is in a growing phase and is mainly driven by the government’s healthcare initiatives. An evolving gas & oil industry and limited diversification into other sectors have significantly constrained the pharma manufacturing activities.
Despite having limited diversification for other sectors, the country has one of the best healthcare infrastructures across the Gulf Cooperation Council (GCC). The increasing population of Kuwait, changing lifestyles, and rising health issues are boosting the demand for better healthcare infrastructure.
Currently, the country has only one pharmaceutical manufacturing company, and there is a high demand for medicines due to the burden of various diseases, creating opportunities for manufacturers to invest in Kuwait. Although the country has a wide presence of pharmaceutical giants, such as Pfizer, Bayer, and Novartis, they can only supply medicines through collaborations with local distributors.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account